# Mutation, round 17, Candidate 2: Documentary Credit Discrepancy Predictor

Fresh mutation agent. Read `MUTATION-BRIEF.md`, `METHOD.md` Part 1 (lines 34-291) and Part 5 (lines
670-754), `STATE.md` -> THE ROOM, `ideation-A.md` lines 79-158, and `screen-A2.md` in full. No new
fetches were needed to answer this question (see section 6); no other files, and no `predictions/`,
were read.

---

## 1. ANSWER: NONE

The screen's own proposed lead does not clear Part 5's threshold test. No other evidence in the screen
forces a tuple change either. No principled mutation exists for this candidate on this evidence.

---

## 2. Why the screen's named lead is not a mutation

The screen (section 5) proposes: *"a formulation that positions as a decision layer sitting on top of
an exporter's existing document-prep tool (its own or a competitor's), scoring only the residual
bank-specific leniency question."*

Testing this against the five tuple elements from `ideation-A.md` lines 83-98:

- **Customer**, small-to-mid exporters (under 500 employees), LC-monthly, no in-house trade-finance
  specialist. **Unchanged.** The lead names no different buyer.
- **Asset**, "a private ledger of past document sets this exporter presented ... matched against what
  THIS exporter's specific issuing/confirming bank and examiner actually did ... which captures
  bank-specific and examiner-specific leniency that the plain UCP 600 text cannot." **Unchanged.** The
  asset was already, on its face, nothing but the bank/examiner-specific leniency signal, read the
  quote again: it never claimed to own the mechanical UCP-matching layer. "Scoring only the residual
  bank-specific leniency question" restates the asset definition; it does not narrow it to something new.
- **Document set / state input**, draft document set plus LC terms, scored before presentation.
  **Unchanged.**
- **The mistake**, presenting a document set the examiner finds discrepant under UCP 600 strict
  compliance. **Unchanged.**
- **The checker**, the issuing/confirming/negotiating bank's examiner under UCP 600 Arts. 14/16.
  **Unchanged.**

Zero of five tuple elements move. What the lead actually proposes is a **distribution decision**, sell
as a bolt-on layer over Traydstream-class tooling (or the exporter's own drafting software) rather than
as a standalone product. `METHOD.md` Part 5 states this exact case by name: *"A proposal that changes
NONE of the five tuple elements ... is not a mutation; it is positioning or pricing and belongs at stage
6."* The screen's own text agrees with itself here, it calls the lead *"a proposal for Veer's
consideration, not a mutation performed here"*, but the brief for this round requires testing it
against M1/M4/M5b/M6 rather than accepting that hedge, so the test is run below in full and reaches the
same place.

One more tell that this is packaging, not reformulation: the "layer on top of an existing drafting tool"
framing is not even new information the screen surfaced. The ideation file's own section 4 (Question
shape) already frames the product as sitting alongside iterative redrafting, *"exporters redraft the
same document set several times before presentation, and want instant feedback on each edit"*, which is
the same "sits on top of drafting" shape the screen's lead re-describes. The screen found evidence that
the mechanical layer is commoditized (Traydstream, JPMorgan); it did not find evidence that the candidate
was ever trying to own that layer, so there is nothing here to retreat from.

---

## 3. M1, forcing evidence, tested and found absent

M1 requires a specific piece of evidence that forces the change. The screen's candidate forcing evidence
is: *"Traydstream's own page plus JPMorgan's own checklist"*, both establishing that mechanical
UCP-matching is already commoditized (screen section 5, and rung-3/rung-4 weaknesses).

This evidence is real (VERIFIED, fetched directly per the screen) but it is **confirmatory, not
forcing**. It confirms a distinction the candidate already drew for itself in `ideation-A.md` line 100-103
(*"An incumbent would already have to be claiming it can predict, bank-by-bank and examiner-by-examiner,
which specific document variances THIS exporter's own bank has actually waived versus rejected in the
past, not merely that it can run a UCP 600 text-matching checklist ... existing LC-checking software
already does the latter for free or near it"*). The candidate's differentiated claim, written before this
screen ran, already excludes the mechanical layer from what the asset is. Evidence that confirms an
existing premise is not evidence that forces a new one. **M1 fails: no new fact changes what the asset,
customer, document set, mistake or checker are.**

---

## 4. M4, original heaviest weakness, and whether the lead escapes it

No kill fired (screen section 3: K1 not fired, K2 not fired, K3 CANDIDATE not fired, K4 not run). Per the
mutation brief's instruction to name the heaviest weakness in the absence of a kill: the screen's own
rubric table gives the lowest score to **criterion 3, significance and magnitude of unmet need (score 2)**
,  driven by the modest verified D1 ($50-130/set) and the UNRUN, negative-leaning D3, not by competitive
crowding.

The screen's proposed lead targets **criterion 4** (differentiation), which scored 3, a full point above
the actual floor, because Traydstream/ICC/JPMorgan already cover the mechanical half of the claim.
Repositioning as a bolt-on layer might, at best, sharpen how the pitch is worded on criterion 4. It does
nothing to criterion 3: it manufactures no new dollar figure, resolves no part of the D3 UNRUN state, and
does not touch the rung-5b confound (buyer's own willingness to waive muddying the waive/reject label).
**A reformulation that leaves the floor criterion untouched has not escaped the candidate's actual
weakness, it has re-decorated a criterion that was never the floor.** M4 fails on its own terms even
before M1 is considered.

---

## 5. M5b, the customer must not change

Not violated, though the point is moot since section 2 already established this is not a mutation. The
lead's exporter segment (small-to-mid, LC-monthly, under 500 employees, no in-house trade-finance
specialist) is identical to `ideation-A.md` line 84-86. No different payer is proposed. No NEW CANDIDATE
LEAD applies here either, nobody's identity as the payer changes; a channel partnership with a
drafting-tool vendor is a go-to-market choice, not a different customer.

---

## 6. M6, re-answer stage 0 for the (unmutated) candidate

Since no mutation is warranted, M6 is answered for the candidate as it already stands in `ideation-A.md`,
against `STATE.md` -> THE ROOM:

- **Can it still name a customer SEGMENT and band, with a countable source?** Segment: yes, named and
  unchanged (small-to-mid exporters under 500 employees, LC-monthly, no in-house specialist). Countable
  source: **partial**, unchanged from the screen's own finding, the Federal Reserve source
  (https://www.federalreserve.gov/econres/notes/feds-notes/trade-finance-activities-of-u-s-banks-what-the-data-can-tell-us-20260508.html)
  is VERIFIED for **bank-side** LC volume (*"Commercial letters of credit: approximately $15 billion"*
  outstanding), not for a customer count in the named segment, this gap is real and was already scored
  on criterion 6 in the screen; it is not something this mutation review can close, since closing it would
  require new search, which is outside this review's remit (test the named lead, not re-run rung 6).
- **Does it still fit the room gate?** Yes, unaffected by anything in this review: a scoring API (product)
  over a private ledger (data asset), not a services engagement; nothing here touches funding, revenue or
  Purdue IP posture, so the eligibility caps ($10k funding / $5k revenue / no Purdue IP) are untouched.

Room gate and segment-naming both hold at the same strength they held before this review; neither was
put at risk by testing the lead, and neither is improved by rejecting it.

---

## 7. VERIFIED / NOT VERIFIED

No new fetches were performed. This review's task was to test the screen's own named lead against
M1/M4/M5b/M6 using the evidence the screen already gathered and quoted with URLs, not to gather new
market evidence, so no new claim requiring a fresh URL was made. Every quote above is reproduced
verbatim from `ideation-A.md` (lines 79-158) or `screen-A2.md`, both already carrying their own
VERIFIED/NOT VERIFIED citations, which are not re-litigated here. Nothing in this file should be read as
adding a new VERIFIED finding to the candidate's record.

---

## Summary (under 150 words)

ANSWER: NONE. The screen's own named lead, repositioning as a decision layer bolted onto an existing
document-prep tool, scoring only the residual bank-specific leniency, changes zero of the five tuple
elements (customer, asset, document set, mistake, checker all identical to `ideation-A.md`). The asset was
already, by its own original definition, nothing but the bank/examiner-specific leniency signal; the
"new" framing restates it. M1 fails: the cited evidence (Traydstream, JPMorgan) confirms a distinction the
candidate already drew, it does not force a new one. M4 fails independently: the lead targets criterion 4
(differentiation, scored 3), not criterion 3 (magnitude, the actual floor at 2), so even if accepted it
would not escape the candidate's heaviest weakness. M5b holds (customer unchanged) but is moot. M6:
segment-naming and room-gate fit are unchanged and unaffected. No kill fired in the screen, so there was
no kill to escape in the first place.
